x

Apogee Therapeutics, Inc. (Nasdaq:APGE)

Health Care/Life Sciences • Biotechnology
CIK 1974640
Company

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in February 2022 and is headquartered in Waltham, MA.

Address
221 Crescent Street
Building 17, Suite 102b
Waltham, Massachusetts 02453
Employees
None
Stock Info
Close
$59.30
Day Range
52.89 - 65.41
52 Week Range
14.19 - 65.41
Average volume
455.11K
Short Interest
3.3M (02/15/24)
% of Float Shorted
11.82%
Market Cap
$2.12B
Revenue
N/A
Net Income
-$39.79M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
N/A
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Mark C Mckenna MBA
Chief Executive Officer & Director
Michael Henderson MD
Director
William A Jones Jr., MBA
Director
Andrew Gottesdiener MBA
Director
Tomas Kiselak
Director
Nimish P Shah MBA
Director
Peter Harwin
Independent Director
Jennifer Fox
SEC filings
DateFormEvent
4 Sep, 2024 144
23 Aug, 2024 4
23 Aug, 2024 144
19 Aug, 2024 8-K
12 Aug, 2024 S-3ASR
12 Aug, 2024 S-8
12 Aug, 2024 8-K
12 Aug, 2024 10-Q
9 Aug, 2024 4
9 Aug, 2024 4
7 Aug, 2024 144
5 Jul, 2024 4
5 Jul, 2024 4
5 Jul, 2024 144
3 Jul, 2024 144
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 8-K
30 May, 2024 4
30 May, 2024 3
28 May, 2024 8-K
28 May, 2024 DEFA14A
15 May, 2024 8-K
13 May, 2024 10-Q
13 May, 2024 S-8
13 May, 2024 8-K
24 Apr, 2024 DEF 14A
24 Apr, 2024 DEFA14A
24 Apr, 2024 ARS
1 Apr, 2024 4
1 Apr, 2024 SC 13D/A
25 Mar, 2024 8-K
11 Mar, 2024 424B4
7 Mar, 2024 EFFECT
7 Mar, 2024 S-1MEF
5 Mar, 2024 8-K
5 Mar, 2024 8-K
5 Mar, 2024 S-1
5 Mar, 2024 10-K
5 Mar, 2024 CORRESP
5 Mar, 2024 CORRESP
29 Feb, 2024 UPLOAD
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G/A
9 Feb, 2024 DRS
9 Feb, 2024 SC 13G/A
31 Jan, 2024 4
31 Jan, 2024 SC 13D/A
20 Dec, 2023 4
20 Dec, 2023 4
20 Dec, 2023 4
13 Nov, 2023 10-Q
13 Nov, 2023 8-K
3 Nov, 2023 SC 13G
28 Aug, 2023 8-K
28 Aug, 2023 S-8
28 Aug, 2023 10-Q
21 Aug, 2023 8-K
21 Aug, 2023 4
21 Aug, 2023 3
10 Aug, 2023 SC 13G
7 Aug, 2023 8-K
28 Jul, 2023 SC 13D
25 Jul, 2023 SEC STAFF
24 Jul, 2023 SC 13G
21 Jul, 2023 SC 13D
17 Jul, 2023 3/A
17 Jul, 2023 4
17 Jul, 2023 4
17 Jul, 2023 424B4 IPO completed
17 Jul, 2023 4
17 Jul, 2023 3/A
17 Jul, 2023 3/A
17 Jul, 2023 3/A
17 Jul, 2023 3/A
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 S-1MEF
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
13 Jul, 2023 3
12 Jul, 2023 CERT
11 Jul, 2023 CORRESP
11 Jul, 2023 CORRESP
10 Jul, 2023 CORRESP
10 Jul, 2023 8-A12B
10 Jul, 2023 S-1/A
3 Jul, 2023 S-1/A
30 Jun, 2023 UPLOAD
22 Jun, 2023 S-1
22 Jun, 2023 CORRESP
16 Jun, 2023 UPLOAD
12 Jun, 2023 SEC STAFF
5 Jun, 2023 DRS/A
5 Jun, 2023 DRSLTR
2 Jun, 2023 UPLOAD
28 Apr, 2023 DRS
Last update:2024-03-06 12:23:29.640029
Apogee Therapeutics, Inc. by TradingView

Sign Up to Subscribe